Published in Kidney Int on July 19, 2006
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73
Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension (2009) 2.97
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int (2011) 1.74
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrol Dial Transplant (2015) 1.42
Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol (2013) 1.23
Sudden cardiac death in chronic kidney disease: epidemiology and prevention. Nat Rev Nephrol (2011) 1.17
Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients. Am J Kidney Dis (2011) 1.09
Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol (2009) 1.09
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant (2014) 1.07
Assessment and management of hypertension in patients on dialysis. J Am Soc Nephrol (2014) 1.07
Antihypertensive agents in hemodialysis patients: a current perspective. Semin Dial (2010) 1.02
Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol (2012) 1.02
Pharmacotherapy of Hypertension in Chronic Dialysis Patients. Clin J Am Soc Nephrol (2016) 0.96
Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clin J Am Soc Nephrol (2010) 0.95
Chronic kidney disease and cardiovascular complications. Heart Fail Rev (2015) 0.95
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias. Adv Chronic Kidney Dis (2014) 0.92
Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol (2010) 0.91
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. Kidney Int (2009) 0.90
Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis. J Am Soc Nephrol (2011) 0.90
Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One (2015) 0.90
An update on coronary artery disease and chronic kidney disease. Int J Nephrol (2014) 0.89
Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature. Heart Fail Rev (2013) 0.86
Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. J Am Soc Nephrol (2009) 0.84
Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. BMC Nephrol (2012) 0.84
Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations. Pediatr Nephrol (2011) 0.83
Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol (2011) 0.83
Left ventricular dysfunction in the haemodialysis population. NDT Plus (2008) 0.81
Evidence-based cardiology in hemodialysis patients. J Am Soc Nephrol (2013) 0.81
Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy. Clin J Am Soc Nephrol (2010) 0.80
The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel? J Am Soc Nephrol (2012) 0.80
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J (2011) 0.80
Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease. Curr Cardiol Rev (2015) 0.79
Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int (2014) 0.78
Sudden Cardiac Death Among Hemodialysis Patients. Am J Kidney Dis (2017) 0.78
Can we reduce the cardiovascular risk in peritoneal dialysis patients? Indian J Nephrol (2010) 0.78
Association between higher rates of cardioprotective drug use and survival in patients on dialysis. Res Social Adm Pharm (2014) 0.78
Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease. Curr Opin Nephrol Hypertens (2014) 0.77
Pharmacologic management of chronic reno-cardiac syndrome. Curr Heart Fail Rep (2013) 0.77
Conformational changes of blood ACE in chronic uremia. PLoS One (2012) 0.77
Protective measures against ultrafiltration failure in peritoneal dialysis patients. Clinics (Sao Paulo) (2011) 0.77
Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol (2016) 0.76
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease. Semin Nephrol (2017) 0.75
Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD). Physiol Rep (2016) 0.75
Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review. BMC Nephrol (2017) 0.75
The Authors Reply. Kidney Int (2015) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Hypertension in dialysis and kidney transplant patients. Can J Cardiol (2009) 0.75
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol (2017) 0.75
Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps. J Am Coll Cardiol (2011) 0.75
Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore) (2017) 0.75
Impact of use of angiotensin II receptor blocker on all-cause mortality in hemodialysis patients: prospective cohort study using a propensity-score analysis. Clin Exp Nephrol (2015) 0.75
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems. Biochim Biophys Acta (1978) 4.66
Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation (2003) 3.68
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. Circulation (2008) 2.67
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Climacteric and menopause in seven South-east Asian countries. Maturitas (1994) 2.32
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2003) 2.28
EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed (1997) 2.26
European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol (2012) 2.20
EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol (1998) 2.08
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Maintaining a hip registry for 25 years. Mayo Clinic experience. Clin Orthop Relat Res (1997) 1.83
Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet (1993) 1.72
A conservative femoral replacement for total hip arthroplasty. A prospective study. J Bone Joint Surg Br (2000) 1.67
Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med (1990) 1.67
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol (2000) 1.66
Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation (2001) 1.64
Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets (2007) 1.64
Pta1, a component of yeast CF II, is required for both cleavage and poly(A) addition of mRNA precursor. Mol Cell Biol (1999) 1.59
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
Genetic heterogeneity of Alport syndrome. Kidney Int (1985) 1.55
Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant (1989) 1.48
Biochemistry of the Na+, D-glucose cotransporter of the small-intestinal brush-border membrane. The state of the art in 1984. Biochim Biophys Acta (1984) 1.48
Practice patterns and family life--a survey of Melbourne medical graduates. Med J Aust (1989) 1.47
Gitelman syndrome comes of age. Nephrol Dial Transplant (1998) 1.47
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrol Dial Transplant (1992) 1.46
Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart (2005) 1.45
[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. Arch Mal Coeur Vaiss (2005) 1.45
Observations of barroom drinking; methodology and preliminary results. Q J Stud Alcohol (1974) 1.44
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study. Am J Transplant (2006) 1.44
The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol (1999) 1.44
The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric (2004) 1.42
Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol (1996) 1.42
Superficial thrombophlebitis of the legs: still a lot to learn. J Thromb Haemost (2005) 1.41
Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial. Clin Ther (2000) 1.40
Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol (1994) 1.39
[Beta-blockers in the treatment of heart failure]. Presse Med (1990) 1.39
[Annual incidence of IgA nephropathy (Berger disease) and Henoch-Schölein purpura in eastern France]. Presse Med (1994) 1.39
Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ (2009) 1.39
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation (1989) 1.38
Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project. Eur Heart J (1996) 1.38
Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med (2002) 1.38
Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38
Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators. Eur Heart J (1995) 1.37
Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.35
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol (1999) 1.34
The clinical spectrum of hereditary nephritis. Kidney Int (1985) 1.33
Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol (2000) 1.32
Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest (1983) 1.29
Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int (1973) 1.27
Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant (1990) 1.26
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Enhancement by an ampakine of memory encoding in humans. Exp Neurol (1997) 1.24
Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail (2001) 1.23
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp (1985) 1.20
Nectar sugar composition and concentration in relation to pollination syndromes in Bromeliaceae. Plant Biol (Stuttg) (2008) 1.20
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20
Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis (1997) 1.19
Labeling of human erythrocyte membranes with eosin probes used for protein diffusion measurements: inhibition of anion transport and photo-oxidative inactivation of acetylcholinesterase. Biochim Biophys Acta (1979) 1.17
Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol (1993) 1.17
Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol. Am J Cardiol (1990) 1.16
Pregnancy in women with impaired renal function. Clin Nephrol (1997) 1.16
Human RNA polymerase II can prematurely terminate transcription of the adenovirus type 2 late transcription unit at a precise site that resembles a prokaryotic termination signal. Virus Genes (1987) 1.15
Effects of 4-aminopyridine at the frog neuromuscular junction. J Pharmacol Exp Ther (1977) 1.15
Renal vascular lesions in lupus nephritis. Medicine (Baltimore) (1997) 1.14
RNA secondary structure is an integral part of the in vitro mechanism of attenuation in simian virus 40. J Biol Chem (1989) 1.14
Studies on in vitro colony formation by mouse bone marrow cells using different inflammatory pleural exudates. Relation to colony stimulating factor (CSF). Exp Hematol (1980) 1.14
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int (1990) 1.13
[Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants]. Pathol Biol (Paris) (1983) 1.13
Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12
Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11
Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant (1995) 1.11
The small-intestinal Na+, D-glucose cotransporter: an asymmetric gated channel (or pore) responsive to delta psi. J Membr Biol (1983) 1.11
Phlorizin as a probe of the small-intestinal Na+,D-glucose cotransporter. A model. Biochim Biophys Acta (1982) 1.11
Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients. Nephrol Dial Transplant (1997) 1.09
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. Br J Psychiatry (1997) 1.08
IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est. Nephrol Dial Transplant (1997) 1.08
Acute renal artery thrombosis associated with factor V Leiden mutation. Nephrol Dial Transplant (1996) 1.07
The effects of adenosine on the development of long-term potentiation. Neurosci Lett (1990) 1.07
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. Am J Transplant (2006) 1.07
Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis (1998) 1.07
Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest (1972) 1.07
Increased reproductive success of MHC class II heterozygous males among free-ranging rhesus macaques. Hum Genet (2001) 1.06
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
Transcription termination in animal viruses and cells. Gene (1988) 1.06
Toxicological and pharmacological properties of clomethiazole. Acta Psychiatr Scand Suppl (1966) 1.06
Structural validity of MADRS during antidepressant treatment. Int Clin Psychopharmacol (1995) 1.06
Menopausal experiences of Thai women. Part 1: Symptoms and their correlates. Maturitas (1997) 1.05
A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity. J Am Coll Cardiol (1987) 1.05
Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. I: Demographic factors. J Biosoc Sci (1997) 1.05
Renal prognosis in women with hereditary nephritis. Clin Nephrol (1985) 1.05
[Electrophysiological analysis of the effects of imipramine on heart ventricle fibre]. Arch Int Pharmacodyn Ther (1969) 1.05
Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys (1986) 1.05